S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET

• Yu-Hung Wang,
• Chien-Chin Lin,
• Chi-Yuan Yao,
• Kristian Gurashi,
• Fabio M. R. Amaral,
• Luciano Nicosia,
• Bettina Wingelhofer,
• Kiran Batta,
• Daniel Wiseman,
• Hsin-An Hou,
• Wen Chien Chou,
• Hwei-Fang Tien

Affiliations

Yu-Hung Wang

1 National Taiwan University Hospital, Taiwan

Chien-Chin Lin

1 National Taiwan University Hospital, Taiwan

Chi-Yuan Yao

1 National Taiwan University Hospital, Taiwan

Kristian Gurashi

2 University of Manchester, United Kingdom

Fabio M. R. Amaral

3 Cancer Research UK Manchester Institute, United Kingdom

Luciano Nicosia

3 Cancer Research UK Manchester Institute, United Kingdom

Bettina Wingelhofer

3 Cancer Research UK Manchester Institute, United Kingdom

Kiran Batta

2 University of Manchester, United Kingdom

Daniel Wiseman

2 University of Manchester, United Kingdom

Hsin-An Hou

1 National Taiwan University Hospital, Taiwan

Wen Chien Chou

1 National Taiwan University Hospital, Taiwan

Hwei-Fang Tien

1 National Taiwan University Hospital, Taiwan